Cooperative Agreements With Commercial Firms
| Published date | 16 November 2020 |
| Record Number | 2020-24529 |
| Section | Rules and Regulations |
| Court | National Aeronautics And Space Administration |
Federal Register, Volume 85 Issue 221 (Monday, November 16, 2020)
[Federal Register Volume 85, Number 221 (Monday, November 16, 2020)]
[Rules and Regulations]
[Page 72919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24529]
[[Page 72919]]
-----------------------------------------------------------------------
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
14 CFR Part 1274
[Document Number NASA-20-092; Docket Number NASA-2020-0007]
RIN 2700-AE58
Cooperative Agreements With Commercial Firms
AGENCY: National Aeronautics and Space Administration (NASA).
ACTION: Direct final rule.
-----------------------------------------------------------------------
SUMMARY: This direct final rule removes information on NASA's
Cooperative Agreements with Commercial Firms because this information
is already available in another section of the Code of Federal
Regulations and in NASA's Grant and Cooperative Agreements Manual
(GCAM).
DATES: This direct final rule is effective on January 15, 2021 without
further action, unless adverse comment is received by December 16,
2020. If adverse comment is received, NASA will publish a timely
withdrawal of the rule in the Federal Register.
ADDRESSES: Comments must be identified with RINs 2700-AE58 and may be
sent to NASA via the Federal E-Rulemaking Portal: http://www.regulations.gov. Follow the online instructions for submitting
comments. Please note that NASA will post all comments on the internet
without changes, including any personal information provided.
FOR FURTHER INFORMATION CONTACT: Antanese Crank, 202-358-4683,
[email protected].
SUPPLEMENTARY INFORMATION:
Direct Final Rule and Significant Adverse Comments
NASA has determined this rulemaking meets the criteria for a direct
final rule because it makes nonsubstantive changes to remove
information on NASA's Cooperative Agreements with Commercial Firms
codified in 14 CFR part 1274 because this information is already
available in 2 CFR part 1800 and in NASA's GCAM. NASA's GCAM is
accessible at https://prod.nais.nasa.gov/pub/pub_library/srba/documents/Grant_and_CooperativeAgreementManual.pdf. No opposition to
the changes and no significant adverse comments are expected. However,
if NASA receives any significant adverse comments, it will withdraw
this direct final rule by publishing a document in the Federal
Register. A significant adverse comment is one that explains: (1) Why
the direct final rule is inappropriate, including challenges to the
rule's underlying premise or approach; or (2) why the direct final rule
will be ineffective or unacceptable without a change. In determining
whether a comment necessitates withdrawal of this direct final rule,
NASA will consider whether such comment warrants a substantive response
through a notice and comment process.
Background
Title 14 CFR part 1274, last amended June 3, 2016 [81 FR 35584],
sets forth policy guidelines to establish uniform requirements for NASA
cooperative agreements awarded to commercial firms. It is amended to
remove information on NASA's Cooperative Agreements with Commercial
Firms because this information is already available in other documents.
Regulatory Analysis
Executive Order 12866, Regulatory Planning and Review and Executive
Order 13563, Improvement Regulation and Regulation Review
Executive Orders (E.O.) 13563 and 12866 direct agencies to assess
all costs and benefits of available regulatory alternatives and, if
regulation is necessary, to select regulatory approaches that maximize
net benefits (including potential economic, environmental, public
health and safety effects, distributive impacts, and equity). E.O.
13563 emphasizes the importance of quantifying both costs and benefits,
of reducing costs, of harmonizing rules, and of promoting flexibility.
This rule has been designated as ``not significant'' under section 3(f)
of E.O. 12866.
Review Under the Regulatory Flexibility Act
The Regulatory Flexibility Act (5 U.S.C. 601 et seq.) requires an
agency to prepare an initial regulatory flexibility analysis to be
published at the time the proposed rule is published. This requirement
does not apply if the agency ``certifies that the rule will not, if
promulgated, have a significant economic impact on a substantial number
of small entities'' (5 U.S.C. 603). This rule removes 14 CFR part 1274,
therefore, does not have a significant economic impact on a substantial
number of small entities.
Review Under the Paperwork Reduction Act
This direct final rule does not contain any information collection
requirements subject to the Paperwork Reduction Act of 1995 (44 U.S.C.
3501 et seq.).
Review Under E.O. 13132
E.O. 13132, ``Federalism,'' 64 FR 43255 (August 4, 1999) requires
regulations be reviewed for federalism effects on the institutional
interest of states and local governments, and if the effects are
sufficiently substantial, preparation of the Federal assessment is
required to assist senior policy makers. Removal of 14 CFR part 1274
will not have any substantial direct effects on state and local
governments within the meaning of the E.O. Therefore, no federalism
assessment is required.
Executive Order 13771--Reducing Regulations and Controlling Regulatory
Costs
This rule is not an E.O. 13771 regulatory action because this rule
is not significant under E.O. 12866.
Unfunded Mandates Reform Act of 1995
This rule will not result in the expenditure by state, local, and
Tribal governments, in the aggregate, or by the private sector, of
$100,000,000 or more in any one year, and it will not significantly or
uniquely affect small governments.
List of Subjects in 14 CFR Part 1274
Federal financial assistance.
PART 1274--[Removed and Reserved]
0
Accordingly, under 51 U.S.C. 20113(a), 14 CFR chapter V is amended by
removing and reserving part 1274.
Nanette Smith,
Team Lead, NASA Directives and Regulations.
[FR Doc. 2020-24529 Filed 11-13-20; 8:45 am]
BILLING CODE 7510-13-P
